肺动脉血流限制器植入在高危先天性心脏病合并肺循环过度新生儿中的结局
该回顾性研究评估了11例复杂先天性心脏病合并肺循环过度的新生儿,采用开窗Medtronic微血管塞作为肺动脉血流限制器进行初始姑息治疗。中位植入年龄48天、体重2.8千克,植入后体重增长20.31克/天,所有患者均桥接至目标手术,9/11实现1年生存,装置取出无需肺动脉重建。
要点
- 高危复杂先心病合并肺循环过度新生儿可考虑肺动脉血流限制器姑息治疗。
- 装置取出可行且无需肺动脉重建,1年随访仅3/22支肺动脉轻度狭窄。
- 并发症包括肺循环过度、血流限制过度、装置释放失败及位置异常。
核心结论
- 高危复杂先心病合并肺循环过度新生儿接受肺动脉血流限制器姑息治疗后结局良好。
主要发现
- 植入后体重增长20.31克/天,植入前为3.75克/天。
- 所有患者均桥接至目标手术,其中双心室修复9例、单心室姑息2例。
- 目标手术后院内死亡1例,11例中9例实现1年生存。
- 1年超声随访显示22支肺动脉中3支轻度狭窄。
- 并发症包括肺循环过度2例(双侧装置移位1例、栓塞1例)、血流限制过度1例、装置释放失败1例、位置异常1例。
临床怎么用
- 对于高危复杂先心病合并肺循环过度的新生儿,可考虑使用开窗Medtronic微血管塞行肺动脉血流限制器姑息治疗。
- 装置取出时无需肺动脉重建,但需注意装置移位、栓塞及血流限制过度等并发症。
局限性
- 回顾性研究,样本量仅11例。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Surgical outcomes in neonates with complex congenital heart disease (CHD) and pulmonary overcirculation (POC) initially palliated with pulmonary flow reducers (PFRs) were evaluated. METHODS: This was a retrospective study conducted between January 1, 2020 and December 31, 2023. Eleven neonates underwent PFR palliation. Fenestrated Medtronic microvascular plugs (PFRs) were delivered into the branch pulmonary artery (PA). The target surgical procedure involved the removal of PFRs and biventricular repair (n = 9) or single-ventricle palliation (n = 2). RESULTS: Patients were deemed high risk on the basis of prematurity (n = 5), early gestational age (n = 5), heterotaxy (n = 1), hypoxic-ischemic encephalopathy (n = 1), chromosomal abnormality (n = 4), or complex intracardiac anatomy (n = 4). Median age and weight at PFR implantation (PFRI) were 48 days (interquartile range [IQR], 16-85 days) and 2.8 kg (IQR, 1.7-3.4 kg), respectively. Median PFRI time was 84 days (IQR, 33-202 days). Weight gain after PFRI was 20.31 g/d vs 3.75 g/d before PFRI. Complications of PFRI included POC in 2 patients (bilateral PFR migration [n = 1] and embolization [n = 1]), excessive flow restriction (n = 1), PFR release failure (n = 1), and malposition (n = 1). All patients were bridged to the target surgical procedure. Devices were surgically removed without the need for PA reconstruction. There was 1 in-hospital mortality after targeted surgery, and 9 of 11 patients achieved 1-year survival. One-year echocardiographic follow-up showed 3 of 22 PAs with mild stenosis. CONCLUSIONS: Outcomes in high-risk neonates with complex CHD and POC are good after PFR palliation. Removal of PFRs is feasible without PA stenosis.
引用
- Buyukgoz C, Sathanandam S, Tailor N, et al. Outcomes After Pulmonary Artery Flow Reducer Implantation in High-Risk Neonates With Congenital Heart Disease and Pulmonary Overcirculation. Ann Thorac Surg. 2025. PMID: 41046011. doi:10.1016/j.athoracsur.2025.08.061
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。